These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2481958)

  • 1. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.
    Westerink MA; Campagnari AA; Nelson MB; Murphy TF; Apicella MA
    Adv Exp Med Biol; 1989; 251():17-31. PubMed ID: 2481958
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immune responses to Haemophilus influenzae type b polysaccharide and a polysaccharide-protein conjugate vaccine.
    Kim KS; Wong VK; Adler R; Steinberg EA
    Pediatrics; 1990 Apr; 85(4 Pt 2):648-50. PubMed ID: 2107516
    [No Abstract]   [Full Text] [Related]  

  • 3. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
    Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
    J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
    Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV
    J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
    Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
    Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
    Moxon ER; Hood D; Richards J
    Adv Exp Med Biol; 1998; 435():237-43. PubMed ID: 9498081
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
    Wong VK; Kim KS
    Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
    Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
    Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic considerations for the development of conjugate vaccines.
    Garner CV; Pier GB
    Contrib Microbiol Immunol; 1989; 10():11-7. PubMed ID: 2510971
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
    Triau R
    Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.